Would you consider any form of 'maintenance' therapy for a patient in a CR2 following re-challenge with platinum doublet for small cell lung cancer after first line chemo-IO?
Answer from: Medical Oncologist at Academic Institution
There is no data for any kind of maintenance treatment. IO is continued per protocol, but after that I am not aware of any data to support maintenance therapy.
Comments
Medical Oncologist at East Carolina University There was an Alliance/CALBG phase II trial which s...
There was an Alliance/CALBG phase II trial which s...